Search

everythinglearnresearchcommunity

for

Search:↓

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Certain medications can cause serious side effects, so it's important to report them.

New drug shows promise for better hair growth in baldness treatment.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

ACTH promotes hair growth in mink, but α-MSH does not.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Tacrolimus can cause hair loss in kidney transplant patients.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Triamcinolone acetonide helps scalp grafts grow hair successfully.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Retinol may affect immune responses in people with frequent skin boils.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.